Baxter International continues to underperform Gilead by 3.9% year to date

Media coverage

• Title	Baxter International continues to underperform Gilead by 3.9% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/1/25
  Persons	Robert P. Smith

• Title	Baxter International continues to outperform Alnylam Pharmaceuticals by 2.6% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/1/25
  Persons	Robert P. Smith

• Title	Baxter International continues to underperform Amgen by 2.3% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/1/25
  Persons	Robert P. Smith

• Title	Baxter International continues to outperform Regeneron by 27.9% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	4/1/25
  Persons	Robert P. Smith